Blue Finessence
Blue Finessence
  • Home
  • About Us
  • Services
    • Our Services
    • Company Formation in Europe
  • News
    • Internal News
    • General news
  • Contact
  • Your cart is currently empty.

    Sub Total: $0.00 View cartCheckout

California Planning To Sue Trump Admin Over Revised Child Vaccine Guidelines

Home / Finance / California Planning To Sue Trump Admin Over Revised Child Vaccine Guidelines
California Planning To Sue Trump Admin Over Revised Child Vaccine Guidelines
  • February 20, 2026
  • test
  • 18 Views

California Planning To Sue Trump Admin Over Revised Child Vaccine Guidelines

California Planning To Sue Trump Admin Over Revised Child Vaccine Guidelines

Authored by Aldgra Fredly via The Epoch Times (emphasis ours),

California Attorney General Rob Bonta said on Feb. 17 that the state plans to take legal action against the Trump administration over the recent modifications to the childhood vaccine schedule.

A man holds his 14-month-old son while he gets the MMR vaccine at a clinic in Lubbock, Texas, on March 1, 2025. Jan Sonnenmair/Getty Images

The Centers for Disease Control and Prevention (CDC) on Jan. 5, with backing from Health Secretary Robert F. Kennedy Jr., narrowed the number of vaccines routinely recommended by the childhood schedule.

Bonta told Reuters in an interview that he has mobilized his team to identify the necessary details for a possible complaint against the Department of Health and Human Services (HHS), including jurisdictional and legal grounds for pursuing the lawsuit.

“I like the facts. I like science. I don’t want to give any airtime to his—I mean, just conspiracy [expletive],” Bonta told the news agency, referring to Kennedy’s stance on vaccines.

Bonta did not specify when the state might file or whether it would be a multistate filing. Connecticut Attorney General William Tong, who also spoke to Reuters, indicated that his state may join California in the filing.

The Epoch Times reached out to HHS for comment but did not receive a response by publication time.

The CDC in January issued a revised childhood vaccine schedule that ended broad recommendations for vaccines against rotavirus, influenza, meningococcal disease, hepatitis A, and hepatitis B.

The agency said in a Jan. 5 memo that decisions for those vaccinations should instead be made through “shared clinical decision-making,” which involves discussion between parents and health care providers.

The changes were made after President Donald Trump directed the HHS and CDC to review U.S. vaccine schedules and compare them with those of peer countries. The president named three countries—Denmark, Japan, and Germany—that recommend fewer vaccines and fewer vaccine doses.

At the time, the White House said in a fact sheet that if the HHS and CDC determine that those practices from developed countries are better than U.S. recommendations, they are directed to update the U.S. core childhood vaccine schedule to align with such scientific evidence and best practices, while preserving access to existing vaccines for Americans.

“Practices like the hepatitis B vaccination at birth are standard in the United States, but uncommon in most developed countries, where it is typically only recommended for newborns of mothers who test positive for the infection,” the White House stated in December.

The American Academy of Pediatrics and other groups filed a lawsuit on Jan. 19 seeking to challenge the revised childhood vaccine schedule.

They argued that officials failed to adequately review relevant data or provide satisfactory explanations for the changes. A federal judge heard arguments on Feb. 13 and is considering whether to block the schedule update.

In January, HHS responded after executives of top vaccine companies took aim at the Trump administration in the wake of a series of actions on vaccines.

“Vaccine recommendations are based on the best available gold-standard scientific evidence and public health considerations, not corporate interests,” an HHS spokesperson told The Epoch Times in an email on Jan. 28.

“Under this administration, HHS is not beholden to the pharmaceutical industry. Decisions are made through transparent processes with the sole aim of protecting the health of the American people. Protecting public health and restoring trust will continue to drive HHS’ vaccine policy.”

Zachary Stieber contributed to this report.

Tyler Durden
Thu, 02/19/2026 – 13:40

Tyler DurdenSource

Share:

Previus Post
Whole Foods
Next Post
Trump Has

Leave a comment

Cancel reply

Recent Posts

  • Independent assessment to support establishment of a Future Entity
  • Predisposizione, da parte dell’Agenzia delle entrate, delle bozze dei registri IVA, delle liquidazioni periodiche dell’IVA e della dichiarazione annuale dell’IVA di cui all’articolo 4 del decreto legislativo 5 agosto 2015, n. 127. Ulteriore estensione del periodo sperimentale stabilito con il provvedimento del Direttore dell’Agenzia delle entrate n. 183994 dell’8 luglio 2021 (provvedimento)
  • Istituzione delle causali contributo per il versamento, tramite modello F24, dei contributi all’INPS da destinare ad Enti Bilaterali (risoluzione n. 5)
  • Deadline for challenging your business rates valuation
  • Targeted financial support for aspiring social workers

Recent Comments

  1. validtheme on Digital Camera

Archives

  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025

Categories

  • Finance
  • internal news
  • Italy
  • Uncategorized
  • United Kingdom

Recent Posts

  • Independent assessment to support establishment of a Future Entity
    09 March, 2026Independent assessment to support
  • Predisposizione, da parte dell’Agenzia delle entrate, delle bozze dei registri IVA, delle liquidazioni periodiche dell’IVA e della dichiarazione annuale dell’IVA di cui all’articolo 4 del decreto legislativo 5 agosto 2015, n. 127. Ulteriore estensione del periodo sperimentale stabilito con il provvedimento del Direttore dell’Agenzia delle entrate n. 183994 dell’8 luglio 2021 (provvedimento)
    09 March, 2026Predisposizione, da parte dell’Agenzia
  • 09 March, 2026Istituzione delle causali contributo
  • Deadline for challenging your business rates valuation
    09 March, 2026Deadline for challenging your

Tags

Blue%20Finessence

Excellence decisively nay man yet impression for contrasted remarkably. There spoke happy for you are out. Fertile how old address did showing.

Contact Info

  • Address:CEO Blue FinEssence Ltd Piccadilly Circus 126 London
  • Email:director@bluefinessence.com
  • Phone:004407784915057

Copyright 2024 Bluefinessence. All Rights Reserved by Bluefinessence

  • About Us
  • Our Services